Your session is about to expire
← Back to Search
Photobiomodulation for Temporomandibular Disorder Pain (ULLTRA Trial)
ULLTRA Trial Summary
This trial aims to test if light therapy can help relieve pain from TMD, a gum and jaw disorder. Double-blind, sham-controlled, randomized study used.
ULLTRA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ULLTRA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had facial pain for at least 3 months with a pain intensity of 30 or more.I started treatments like acupuncture or biofeedback within the last 30 days.I have an active rheumatic disease.I do not have any health conditions like severe kidney failure or uncontrolled diabetes that would stop me from joining.I started a new pain management medication within the last 30 days.I haven't had any injection for pain management in the last 14 days.I had facial surgery or injury within the last 6 weeks.I am 18 years old or older.I have been diagnosed with a jaw muscle disorder causing pain.I am currently undergoing chemotherapy or radiation therapy.I am willing and able to follow the study rules and attend all appointments.I started using a dental device for my jaw within the last 30 days.
- Group 1: Experimental: Active PBM
- Group 2: Sham PBM
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this clinical experiment confined to those over a certain age?
"As the inclusion criteria states, this medical trial is only available to those aged 18-65. However, there are 7 trials for minors and 22 additional studies accessible for individuals above 65 years old."
Has the FDA concluded its evaluation of Experimental: Active PBM?
"Our analysis identified Experimental: Active PBM as having an approximate safety rating of 2, given that there is currently only supportive evidence for its protective qualities but no data yet regarding efficacy."
Is eligibility for this research trial open to me?
"This medical trial requires that participants have temporomandibular disorder and are between the ages of 18 to 65. At this time, 130 patients need to be sourced for enrollment."
Are participants being recruited at this juncture for the experiment?
"Clinicaltrials.gov data reveals that this research project, posted October 1st 2023 and last modified on June 14th 2023 is not currently seeking participants. Nevertheless, there are 40 other clinical trials actively recruiting candidates at the present time."
Share this study with friends
Copy Link
Messenger